Martin Duvall

Presidente en

Oncopeptides, Inc.

64 años

69 relaciones

Health Technology

Consumer Services

Health Services

Perfil

Martin J.
Duvall is currently the Chairman of Oncopeptides, Inc. and a Director of Oncopeptides Incentive AB. He was previously the Chief Executive Officer & Director of Tocagen, Inc. and the Chief Executive Officer of Oncopeptides AB. He has also held senior positions at Merck & Co., Inc., MGI PHARMA, Inc., ARIAD Pharmaceuticals, Inc., and Abraxis BioScience, Inc. He was a Vice President at Aventis Pharmaceuticals, Inc. Mr. Duvall has a graduate degree from The Johns Hopkins University, an undergraduate degree from Muhlenberg College, and an MBA from the University of Kansas.

Cargos activos de Martin Duvall

Empresas	Cargo	Inicio
MGI PHARMA Biologics, Inc. MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical and medical therapies	Corporate Officer/Principal	01/11/2004
Oncopeptides, Inc. Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Develops therapies for hematological diseases	Presidente	-
Oncopeptides Incentive AB	Director/Miembro de la Junta	-

Todos los cargos activos de Martin Duvall

Antiguos cargos conocidos de Martin Duvall.

Empresas	Cargo	Fin
ONCOPEPTIDES AB	Director Ejecutivo	15/11/2021
FORTE BIOSCIENCES, INC.	Director Ejecutivo	15/06/2020
ARIAD PHARMACEUTICALS, INC.	Corporate Officer/Principal	26/05/2016
MERCK & CO., INC.	Corporate Officer/Principal	01/09/2011
MGI PHARMA, Inc. MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets	Corporate Officer/Principal	27/04/2011

Ver el detalle de la experiencia de Martin Duvall.

Formación de Martin Duvall.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Martin Duvall.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	13
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
MGI PHARMA, Inc. MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets	Health Technology
ARIAD Pharmaceuticals, Inc. ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer	Health Technology
Abraxis BioScience, Inc. Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products	Health Technology
Tocagen, Inc. Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs	Health Technology
Aventis Pharmaceuticals, Inc. Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Health Technology
The Johns Hopkins University The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Muhlenberg College Muhlenberg College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oncopeptides AB Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment	Health Technology
MGI PHARMA Biologics, Inc. MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical and medical therapies	Health Technology
Oncopeptides Incentive AB
Oncopeptides, Inc. Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Develops therapies for hematological diseases	Health Services